 NEW YORK, Nov. 19, 2020 GLOBE NEWSWIRE -- Daxor Corporation NYSE MKT: DXR, an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that Wake Forest Baptist Health will participate in an ongoing trial to treat patients hospitalized with COVID-19 utilizing Daxors BVA-100 Blood Volume Analyzer, BVA technology. Wake Forest School of Medicine is based in Winston-Salem, North Carolina, and is set to enroll patients under the leadership of Ashish K. Khanna, MD. 